Sponsored Content | Videos | Cardiovascular Ultrasound

Detailed imaging is needed to support complex interventions for the assessment and procedure guidance. See how the GE ...

Home January 13, 2017
Home
News | Mobile Devices

Four organizations have announced they are forming a new, multi-stakeholder collaboration, Xcertia, dedicated to improving the quality, safety and effectiveness of mobile health applications. The initial supporters of the collaboration include the American Heart Association (AHA), the American Medical Association (AMA), DHX Group and the Healthcare Information and Management Systems Society (HIMSS).

Home January 12, 2017
Home
News | FFR Technologies

Acist Medical Systems Inc. announced that enrollment is complete for its Fractional Flow Reserve (FFR) Study – Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement. The study, which began in November 2015, included 240 patients at 12 sites across the United States. Final results are expected to be released in mid-2017.

Home January 12, 2017
Home
News | Cardiac Diagnostics

Experts at Johns Hopkins and New York's Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease. The team said the plan puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.

Home January 12, 2017
Home
Technology | Ultrasound Imaging

GE Healthcare unveiled its new generation of pocket-sized, dual-probe ultrasound, the Vscan Extend. From the hospital and ambulance to more rural environments, Vscan Extend uses high image quality and wireless connectivity to help users increase clinical confidence and improve patient care.

Home January 12, 2017
Home
News | Cardiovascular Business

International healthcare-focused merger and acquisition (M+A) advisory firm Vertess recently shared its vision of how a new healthcare plan from President-elect Donald Trump could impact the healthcare industry.

Home January 12, 2017
Home
EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD
Feature | Stents | Dave Fornell

The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results of ...

Home January 12, 2017
Home
News | Nuclear Imaging

January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source ...

Home January 12, 2017
Home
News | Interventional Radiology

According to a recent study by the Harvey L. Neiman Health Policy Institute, the last two decades have seen a substantial decline in new enteral access procedures in the Medicare population. The study, published online in November in the Journal of Vascular and Interventional Radiology (JVIR), also found that maintenance services have increased, with radiologists and emergency physicians surpassing gastroenterologists and surgeons as the leading providers of those procedures.

Home January 11, 2017
Home
News | Stent Grafts

January 11, 2017 — Lombard Medical Inc. recently announced approval from the Japanese Ministry of Health, Labour and ...

Home January 11, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of treatment is stroke prevention. As a result, most Afib patients are prescribed a blood thinner such as warfarin, also known by the brand name Coumadin, to combat the potential for blood clots that could lead to stroke. But warfarin is tough to manage, and some patients have trouble adhering to any medication. A new research letter published in JAMA Cardiology finds Afib patients are even more likely to discontinue warfarin therapy if they’ve had a recent procedure done to address their arrhythmia.

Home January 11, 2017
Home
Technology | Intravascular Imaging

January 11, 2017 — Avinger Inc. recently announced the U.S. launch of an enhanced version of the company’s Lightbox ...

Home January 11, 2017
Home
News | Heart Failure

BioVentrix Inc. announced in December the first closed-chest Revivent TC TransCatheter Ventricular Enhancement System procedure in Germany since receiving CE mark certification. The Less Invasive Ventricular Enhancement (LIVE) procedure was performed by interventional cardiologists Christian Frerker, M.D. and Tobias Schmidt, M.D., and by cardiothoracic surgeon Ralf Bader, M.D., at Asklepios Klinik St. Georg in Hamburg, Germany. The St. Georg Heart team is led by Prof. Dr. Karl-Heinz Kuck, who is also the chairman of the Department of Cardiology and Electrophysiology.

Home January 10, 2017
Home
News | Stents Drug Eluting

Medinol announced in December positive twelve-month clinical results from the BIONICS study. The study was conducted to evaluate EluNIR, Medinol's novel coronary stent system and the first ever elastomer-coated drug eluting stent (eDES), according to the company.

Home January 10, 2017
Home
News | Heart Failure

Ischemic heart failure from previous heart attacks and coronary artery disease is the leading cause of death in the world, affecting more than 12 percent of the world’s population, according to the World Health Organization. Stem cell therapy has been conducted to try to repair heart damage from ischemic heart failure, but in previous studies, the two types of stem cells (autologous bone marrow derived mesenchymal cells [MSCs] and endomyocardial biopsy derived c-kit+ Cardiac Stem Cells [CSCs]) have been used in separate trials. In a first-in-the-world study, the Minneapolis Heart Institute Foundation (MHIF) is about to begin the CONCERT study, led by Principal Investigator Jay Traverse, M.D. The study will use MSCs and CSCs together to learn if the combination would be more successful than using either alone based on pre-clinical studies in swine demonstrating an enhanced synergistic effect of the combination.

Home January 10, 2017
Home
Subscribe Now